LongueVue Capital Invests in Summit Clinical Research

October 26, 2022

LongueVue Capital completed a growth investment in Summit Clinical Research, an integrated research organization (IRO) headquartered in San Antonio, Texas. The investment will provide financial and human capital to accelerate Summit's growth and expand its clinical trial site network and capabilities, particularly in hepatology and NASH research.

Buyers
LongueVue Capital
Targets
Summit Clinical Research, LLC
Location
Texas, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.